New protocol of myocardial SPECT imaging with technetium-99m sestamibi for reducing the time interval between rest and adenosine stress phases.
We have developed a new protocol of myocardial perfusion-gated single-photon emission computed tomography (SPECT), by use of technetium-99m sestamibi (MIBI), in which SPECT imaging at rest followed by SPECT imaging after adenosine with low level ergometer stress can be conducted by use of the Monzen position within a shortened total testing time of 1 h or less. The study group consisted of 137 patients who underwent this new imaging protocol. The diagnostic quality of the images was as good as that of images obtained with the conventional method (30-60 min after the injection of MIBI). The SPECT image quality for the 137 patients was evaluated, and the percentages of images rated as excellent, good, fair, and poor were 65.3, 27.4, 5.8, and 1.5% for the rest image, and 68.2, 21.9, 8.4, and 1.5% for the stress image, respectively. The shortened total testing time reduced the physical and mental burden on the patient compared with that of conventional myocardial perfusion imaging. Because this technique allows us to perform rest and stress myocardial imaging within a short period, it is expected to be very useful in the clinical setting.
Monzen
Hajime
H
Department of Radiology, Otsu Red Cross Hospital, Otsu-shi, Shiga, Japan. hmrky77@u01.gate01.com
Hara
Masatake
M
Nakanishi
Akira
A
Hirata
Makoto
M
Suzuki
Takatoshi
T
Ogasawara
Makoto
M
Higuchi
Hirokazu
H
Kobayashi
Hisato
H
Yuki
Rumio
R
Hirose
Kunihiko
K
D000241:Adenosine / Q000494:pharmacology*; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006321:Heart / Q000000981:diagnostic imaging* / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D008297:Male; D055414:Myocardial Perfusion Imaging; D015203:Reproducibility of Results; D012146:Rest; D013312:Stress, Physiological / Q000187:drug effects*; D017256:Technetium Tc 99m Sestamibi; D013997:Time Factors; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods*
D017256:Technetium Tc 99m Sestamibi; D000241:Adenosine
Eur J Nucl Med. 1988;13(10):515-22
3371372
J Nucl Med. 1980 Nov;21(11):1015-21
7431099
J Nucl Med. 1994 Apr;35(4):542-8
8151372
J Nucl Cardiol. 2002 Nov-Dec;9(6):622-31
12466787
J Nucl Cardiol. 2008 Mar-Apr;15(2):241-5
18371596
J Nucl Cardiol. 2008 Jan-Feb;15(1):35-41
18242478
J Nucl Cardiol. 2001 Jul-Aug;8(4):482-98
11481571
J Am Coll Cardiol. 2003 Oct 1;42(7):1318-33
14522503
J Nucl Cardiol. 1996 Nov-Dec;3(6 Pt 1):475-82
8989672
Circulation. 1977 Feb;55(2):294-302
832345
Circulation. 2000 Mar 28;101(12):1465-78
10736294
J Am Coll Cardiol. 1994 Apr;23(5):1107-14
8144776
Nucl Med Commun. 1996 Oct;17(10):851-6
8951905
Circ J. 2006 Dec;70(12):1585-9
17127804
Ann Nucl Med. 2006 Dec;20(10):705-10
17385311
Eur J Nucl Med. 1989;15(3):113-7
2785451
J Am Coll Cardiol. 1993 Nov 1;22(5):1455-64
8227805
Circulation. 1979 Apr;59(4):707-13
421309
J Nucl Cardiol. 2000 Nov-Dec;7(6):584-9
11144473
J Nucl Med. 1992 Feb;33(2):186-91
1531069
J Am Coll Cardiol. 1983 Apr;1(4):994-1001
6833659
N Engl J Med. 1976 Jul 1;295(1):1-5
1272283